Aranda Pharma Oy is a Finnish biotechnology research company focused on preclinical stage pharmaceutical development with proprietary R&D programs in dermatology and neurology
Aranda Pharma Oy is a Finnish biotechnology research company focused on preclinical stage pharmaceutical development with proprietary R&D programs in dermatology and neurology. The company has two main product candidates: ADA-308, a topical androgen receptor antagonist for androgenetic alopecia and acne, and ADA-409, a ferroptosis inhibitor for brain diseases.